Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-13
2009-12-01
Crane, Lawrence E. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254010, C514S255030, C544S360000, C544S372000, C544S391000
Reexamination Certificate
active
07625904
ABSTRACT:
The invention relates to methods for the treatment of a sleep disorder in a mammal comprising administering to said mammal an effective amount of a compound of formula (I):wherein all variables are as defined herein.
REFERENCES:
patent: 4087424 (1978-05-01), Saikawa et al.
patent: 4110327 (1978-08-01), Saikawa et al.
patent: 4112090 (1978-09-01), Saikawa et al.
patent: 4219554 (1980-08-01), Saikawa et al.
patent: 4308387 (1981-12-01), Bjork et al.
patent: 4327097 (1982-04-01), Saikawa et al.
patent: 4379152 (1983-04-01), Saikawa et al.
patent: 4410522 (1983-10-01), Saikawa et al.
patent: 5028610 (1991-07-01), Hirai et al.
patent: 5109014 (1992-04-01), Jacobson et al.
patent: 5334606 (1994-08-01), McLeod et al.
patent: 5348955 (1994-09-01), Greenlee et al.
patent: 5360820 (1994-11-01), Hagan et al.
patent: 5464788 (1995-11-01), Bock et al.
patent: 5538982 (1996-07-01), Hagan et al.
patent: 5576317 (1996-11-01), Gonsalves et al.
patent: 5696123 (1997-12-01), Dollinger et al.
patent: 5698538 (1997-12-01), Amparo et al.
patent: 5708006 (1998-01-01), Dollinger et al.
patent: 5710169 (1998-01-01), Russell et al.
patent: 5716942 (1998-02-01), Dorn et al.
patent: 5756504 (1998-05-01), Bock et al.
patent: 5859015 (1999-01-01), Graham et al.
patent: 5952315 (1999-09-01), Baker et al.
patent: 5977104 (1999-11-01), Baker et al.
patent: 5985881 (1999-11-01), Dollinger et al.
patent: 5998444 (1999-12-01), Russell et al.
patent: 6057323 (2000-05-01), Zhang et al.
patent: 6090807 (2000-07-01), Hellendahl et al.
patent: 6114315 (2000-09-01), Baker et al.
patent: 6117855 (2000-09-01), Carlson et al.
patent: 6147083 (2000-11-01), Russell et al.
patent: 6191135 (2001-02-01), Dollinger et al.
patent: 6191139 (2001-02-01), Hagan et al.
patent: 6197772 (2001-03-01), Janssens et al.
patent: 6235732 (2001-05-01), Dollinger et al.
patent: 6319953 (2001-11-01), Carlson et al.
patent: RE37886 (2002-10-01), Janssens et al.
patent: 6521621 (2003-02-01), Janssens et al.
patent: 6642240 (2003-11-01), Alvaro et al.
patent: 6951861 (2005-10-01), Alvaro et al.
patent: 7071196 (2006-07-01), Alvaro et al.
patent: 7345041 (2008-03-01), Alvaro et al.
patent: 2519400 (1976-03-01), None
patent: 287734 (1987-10-01), None
patent: 293532 (1987-10-01), None
patent: 0655442 (1995-05-01), None
patent: 718287 (1995-12-01), None
patent: 1508062 (1975-04-01), None
patent: 57/118587 (1982-07-01), None
patent: WO 92/16211 (1992-10-01), None
patent: WO 95/00498 (1995-01-01), None
patent: WO 95/25443 (1995-09-01), None
patent: WO 96/03378 (1996-02-01), None
patent: WO 96/14844 (1996-05-01), None
patent: WO 96/20173 (1996-07-01), None
patent: WO 97/16440 (1997-05-01), None
patent: WO 97/32865 (1997-09-01), None
patent: WO 97/36592 (1997-10-01), None
patent: WO 97/36593 (1997-10-01), None
patent: WO 97/36888 (1997-10-01), None
patent: WO 97/36889 (1997-10-01), None
patent: WO 98/01133 (1998-01-01), None
patent: WO 98/02158 (1998-01-01), None
patent: WO 98/20001 (1998-05-01), None
patent: WO 98/57954 (1998-12-01), None
patent: WO 99/09985 (1999-03-01), None
patent: WO 99/26921 (1999-06-01), None
patent: WO 01/30348 (2001-05-01), None
patent: WO 02/32867 (2002-04-01), None
patent: WO 02/057233 (2002-07-01), None
patent: WO 2004/033428 (2004-04-01), None
(R) Challet et al. (I), “An NK1 Receptor Antagonist Affects the Circadian Regulation of Locomotor Activity in Golden Hamsters,” Brain Research, 800, 32-39 (1998); copy supplied by applicant in parent case.
(S) Challet et al. (II), “The Selective Neurokinin 1 Receptor Antagonist R116301 Modulates Photic Responses of the Hamster Circadian System,” Neuropharmacology, 40, 408-415 (2001).
(T) Venes et al.(eds.), Taber's Cyclopedic Medical Dictionary, 19th Edition, F. A. Davis Co., Philadelphia, PA, 2001, see especially pp. 149-150 (“sleep apnea”); p. 651 (“dysomnia”); and p. 1415 (“narcolepsy”).
Davis, David T., “Synthesis A. Biological Activity of a Series of Piperazin-2,3-Diones,” Journal of Antibiotics, vol. XLII, No. 3, 1989, pp. 367-373.
Alvaro Giuseppe
Di Fabio Romano
Giovannini Riccardo
Guercio Giuseppe
St-Denis Yves
Crane Lawrence E.
SmithKline Beecham Corporation
Thomas Robert (Steve)
LandOfFree
Methods for the treatment of sleep disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of sleep disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of sleep disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4062936